SMS Pharmaceuticals Ltd

SMS Pharmaceuticals Ltd maintains a debt-to-equity ratio of 0.49, indicating a relatively conservative capital structure. The company's liquidity position is assessed as medium, with a current ratio of 1.71, suggesting it can cover short-term obligations but with limited buffer. However, the company has negative net cash after subtracting total debt, which raises concerns about its ability to meet long-term obligations without additional financing. The company's profitability metrics show a return on equity (ROE) of 10.81% and a return on assets (ROA) of 6.00%. These figures are in line with the industry's preferred metrics, which emphasize ROE and ROA as key indicators of financial performance. The operating margin, calculated as operating income of INR 1,046.67 million on revenue of INR 7,827.48 million, is 13.37%, which is a strong indicator of cost control and pricing power. The company's revenue is concentrated in a few key segments and geographic regions, with the majority of its sales coming from the domestic market. The company's exposure to international markets is limited, which may reduce diversification benefits but also insulate it from foreign exchange volatility. The company's revenue concentration in a single geographic region could pose a risk if domestic demand weakens or regulatory pressures increase. The company's growth trajectory is mixed. Revenue for the latest period was INR 7,827.48 million, and while the outlook for the current fiscal year is positive, the next fiscal year's growth is expected to be more moderate. The company's capital expenditure of INR 1,233.79 million indicates a focus on maintaining and expanding production capacity, which is a positive sign for long-term growth. However, the company's free cash flow is negative at INR -250.31 million, which may limit its ability to fund growth initiatives without external financing. The company's risk profile is characterized by medium liquidity risk and low dilution potential. The risk assessment highlights the negative net cash position as a key flag, which could necessitate additional debt or equity financing in the near term. The company has not indicated any immediate plans for share dilution, and the dilution potential is assessed as low, suggesting that the company is not currently under pressure to raise capital through equity issuance. Recent events and filings do not indicate any material changes in the company's operations or financial position. The company's latest financial statements and disclosures are consistent with its historical performance, and there are no indications of significant regulatory or legal challenges that would impact its operations.